Kevin M.  Brady net worth and biography

Kevin Brady Biography and Net Worth

CFO of Medpace
Kevin M. Brady is the CFO & Treasurer at Medpace Inc.

What is Kevin M. Brady's net worth?

The estimated net worth of Kevin M. Brady is at least $1.87 million as of July 31st, 2023. Mr. Brady owns 6,000 shares of Medpace stock worth more than $1,874,160 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Brady may own. Additionally, Mr. Brady receives a salary of $690,480.00 as CFO at Medpace. Learn More about Kevin M. Brady's net worth.

How old is Kevin M. Brady?

Mr. Brady is currently 49 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Kevin M. Brady's age.

What is Kevin M. Brady's salary?

As the CFO of Medpace Holdings, Inc., Mr. Brady earns $690,480.00 per year. There are 4 executives that earn more than Mr. Brady. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,650,000.00 per year. Learn More on Kevin M. Brady's salary.

How do I contact Kevin M. Brady?

The corporate mailing address for Mr. Brady and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at investor@medpace.com. Learn More on Kevin M. Brady's contact information.

Has Kevin M. Brady been buying or selling shares of Medpace?

Kevin M. Brady has not been actively trading shares of Medpace during the past quarter. Most recently, Kevin M. Brady sold 7,000 shares of the business's stock in a transaction on Monday, July 31st. The shares were sold at an average price of $255.00, for a transaction totalling $1,785,000.00. Following the completion of the sale, the chief financial officer now directly owns 6,000 shares of the company's stock, valued at $1,530,000. Learn More on Kevin M. Brady's trading history.

Who are Medpace's active insiders?

Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.

Are insiders buying or selling shares of Medpace?

In the last twelve months, Medpace insiders bought shares 1 times. They purchased a total of 2 shares worth more than $652.22. In the last twelve months, insiders at the sold shares 5 times. They sold a total of 29,621 shares worth more than $11,816,851.63. The most recent insider tranaction occured on February, 27th when General Counsel Stephen P Ewald bought 2 shares worth more than $652.22. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.

Information on this page was last updated on 2/27/2025.

Kevin M. Brady Insider Trading History at Medpace

See Full Table

Kevin M. Brady Buying and Selling Activity at Medpace

This chart shows Kevin M Brady's buying and selling at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Medpace Company Overview

Medpace logo
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Read More

Today's Range

Now: $312.36
Low: $311.54
High: $317.29

50 Day Range

MA: $335.90
Low: $312.36
High: $360.97

2 Week Range

Now: $312.36
Low: $302.01
High: $459.77

Volume

343,137 shs

Average Volume

298,736 shs

Market Capitalization

$9.52 billion

P/E Ratio

24.73

Dividend Yield

N/A

Beta

1.47